Pharmstandard Acquires To Improve Portfolio

BMI View: Pharmstandard's latest acquisition solidifies and extends existing relationships with two other Russian pharmaceutical companies. While the controlling stake is with a Cypriot holding company, the active firms are Russian-focused. The move will eventually extend Pharmstandard's portfolio of medicines.

To read the full article, please choose one of the following options: